The Coalition for Epidemic Preparedness Innovations unveiled a new biosecurity strategy Wednesday at a side event of the U.N. General Assembly to address emerging global health threats that may “arise naturally, accidentally, or due to deliberate misuse.”
The strategy focuses on strengthening global collaboration, promoting equity, reducing risks from biological research, and accelerating vaccine development using advanced technologies such as artificial intelligence. At its core is CEPI’s 100 Days Mission, an ambitious goal to enable the world to develop life-saving vaccines within 100 days of detecting a new infectious disease threat — potentially saving millions of lives and preventing trillions in economic losses.
It is supported by funding from Global Affairs Canada, which will provide 100 million Canadian dollars toward CEPI's new five-year strategic plan — CEPI 2.0.
About the author
Rumbi Chakamba
Rumbi Chakamba is a Senior Editor at Devex based in Botswana, who has worked with regional and international publications including News Deeply, The Zambezian, Outriders Network, and Global Sisters Report. She holds a bachelor's degree in international relations from the University of South Africa.
